The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study. - Schmit N; Topazian HM; Natama HM; Bellamy D; Traoré O; Somé MA; Rouamba T; Tahita MC; Bonko MDA; Sourabié A; Sorgho H; Stockdale L; et al. (The Lancet. Infectious diseases, 2024)